{"entity":{"type":"insider","cik":"0001399894","url":"/insider/0001399894","json_url":"/insider/0001399894.json","name":"Alta Partners Management VIII, LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":28,"n_filings":15,"first":"2010-01-08","last":"2018-07-23","span_basis":"filed_date"},"name_variants":[{"name":"Alta Partners Management VIII, LLC","source":"filing","n_filings":15,"first_seen":"2010-01-08","last_seen":"2018-07-23"}],"transactions":[{"id":6904891,"accession":"0001209191-18-043627","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-043627","line_url":"/filing/0001209191-18-043627#line-2","is_derivative":false,"issuer_cik":"0001198321","issuer_name":"Allakos Inc.","issuer_ticker":"ALLK","issuer_name_source":null,"issuer_url":"/issuer/0001198321","owner_cik":null,"owner_name":"MORE ROBERT J; NOHRA GUY P; CHAMPSI FARAH; Alta Partners NextGen Fund I Management, LLC; Alta Partners VIII, L.P.; Alta Partners NextGen Fund I, L.P.; Hudson Peter A; Alta Partners Management VIII, LLC","owner_display_name":"MORE ROBERT J","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250000.0,"shares_display":"250,000","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":4500000.0,"total_display":"4,500,000.00","total_whole":"4,500,000","shares_owned_after":11519200.0,"shares_owned_after_display":"11,519,200","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-07-23","filed_date":"2018-07-23","scope":"insider"},{"id":8677811,"accession":"0001209191-15-087403","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-087403","line_url":"/filing/0001209191-15-087403#line-3","is_derivative":false,"issuer_cik":"0001198321","issuer_name":"Neothetics, Inc.","issuer_ticker":"NEOT","issuer_name_source":null,"issuer_url":"/issuer/0001198321","owner_cik":null,"owner_name":"CHAMPSI FARAH; Alta Partners VIII, L.P.; JANNEY DANIEL; Alta Partners Management VIII, LLC; NOHRA GUY P","owner_display_name":"CHAMPSI FARAH","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":250000.0,"shares_display":"250,000","price_per_share":1.44,"price_display":"1.44","price_state":"stated","total_value":360000.0,"total_display":"360,000.00","total_whole":"360,000","shares_owned_after":1339776.0,"shares_owned_after_display":"1,339,776","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-30","filed_date":"2015-12-30","scope":"insider"},{"id":8677809,"accession":"0001209191-15-087403","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-087403","line_url":"/filing/0001209191-15-087403#line-2","is_derivative":false,"issuer_cik":"0001198321","issuer_name":"Neothetics, Inc.","issuer_ticker":"NEOT","issuer_name_source":null,"issuer_url":"/issuer/0001198321","owner_cik":null,"owner_name":"CHAMPSI FARAH; Alta Partners VIII, L.P.; JANNEY DANIEL; Alta Partners Management VIII, LLC; NOHRA GUY P","owner_display_name":"CHAMPSI FARAH","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":493654.0,"shares_display":"493,654","price_per_share":1.53,"price_display":"1.53","price_state":"stated","total_value":755290.62,"total_display":"755,290.62","total_whole":"755,291","shares_owned_after":1589776.0,"shares_owned_after_display":"1,589,776","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-29","filed_date":"2015-12-30","scope":"insider"},{"id":8677807,"accession":"0001209191-15-087403","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-087403","line_url":"/filing/0001209191-15-087403#line-1","is_derivative":false,"issuer_cik":"0001198321","issuer_name":"Neothetics, Inc.","issuer_ticker":"NEOT","issuer_name_source":null,"issuer_url":"/issuer/0001198321","owner_cik":null,"owner_name":"CHAMPSI FARAH; Alta Partners VIII, L.P.; JANNEY DANIEL; Alta Partners Management VIII, LLC; NOHRA GUY P","owner_display_name":"CHAMPSI FARAH","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":54333.0,"shares_display":"54,333","price_per_share":1.59,"price_display":"1.59","price_state":"stated","total_value":86389.47,"total_display":"86,389.47","total_whole":"86,389","shares_owned_after":2083430.0,"shares_owned_after_display":"2,083,430","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-28","filed_date":"2015-12-30","scope":"insider"},{"id":8228227,"accession":"0001209191-15-085832","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-085832","line_url":"/filing/0001209191-15-085832#line-1","is_derivative":false,"issuer_cik":"0001198321","issuer_name":"Neothetics, Inc.","issuer_ticker":"NEOT","issuer_name_source":null,"issuer_url":"/issuer/0001198321","owner_cik":null,"owner_name":"JANNEY DANIEL; Alta Partners VIII, L.P.; NOHRA GUY P; Alta Partners Management VIII, LLC; CHAMPSI FARAH","owner_display_name":"JANNEY DANIEL","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":529261.0,"shares_display":"529,261","price_per_share":1.44,"price_display":"1.44","price_state":"stated","total_value":762135.84,"total_display":"762,135.84","total_whole":"762,136","shares_owned_after":2137763.0,"shares_owned_after_display":"2,137,763","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-15","filed_date":"2015-12-17","scope":"insider"},{"id":8130628,"accession":"0001209191-15-051413","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-051413","line_url":"/filing/0001209191-15-051413#line-2","is_derivative":false,"issuer_cik":"0001198321","issuer_name":"ZS Pharma, Inc.","issuer_ticker":"ZSPH","issuer_name_source":null,"issuer_url":"/issuer/0001198321","owner_cik":null,"owner_name":"Alta Partners Management VIII, LLC; Alta Partners VIII, L.P.; CHAMPSI FARAH; JANNEY DANIEL; NOHRA GUY P","owner_display_name":"Alta Partners Management VIII, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11200.0,"shares_display":"11,200","price_per_share":57.53,"price_display":"57.53","price_state":"stated","total_value":644336.0,"total_display":"644,336.00","total_whole":"644,336","shares_owned_after":2646643.0,"shares_owned_after_display":"2,646,643","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-08","filed_date":"2015-06-09","scope":"insider"},{"id":8130624,"accession":"0001209191-15-051413","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-051413","line_url":"/filing/0001209191-15-051413#line-1","is_derivative":false,"issuer_cik":"0001198321","issuer_name":"ZS Pharma, Inc.","issuer_ticker":"ZSPH","issuer_name_source":null,"issuer_url":"/issuer/0001198321","owner_cik":null,"owner_name":"Alta Partners Management VIII, LLC; Alta Partners VIII, L.P.; CHAMPSI FARAH; JANNEY DANIEL; NOHRA GUY P","owner_display_name":"Alta Partners Management VIII, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":164227.0,"shares_display":"164,227","price_per_share":57.88,"price_display":"57.88","price_state":"stated","total_value":9505458.76,"total_display":"9,505,458.76","total_whole":"9,505,459","shares_owned_after":2657843.0,"shares_owned_after_display":"2,657,843","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-05","filed_date":"2015-06-09","scope":"insider"},{"id":8750373,"accession":"0001209191-15-050701","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-050701","line_url":"/filing/0001209191-15-050701","is_derivative":false,"issuer_cik":"0001198321","issuer_name":"ZS Pharma, Inc.","issuer_ticker":"ZSPH","issuer_name_source":null,"issuer_url":"/issuer/0001198321","owner_cik":null,"owner_name":"JANNEY DANIEL; CHAMPSI FARAH; Alta Partners Management VIII, LLC; NOHRA GUY P; Alta Partners VIII, L.P.","owner_display_name":"JANNEY DANIEL","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":88408.0,"shares_display":"88,408","price_per_share":57.48663220523029,"price_display":"57.49","price_state":"stated","total_value":5082278.18,"total_display":"5,082,278.18","total_whole":"5,082,278","shares_owned_after":2822070.0,"shares_owned_after_display":"2,822,070","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-04","filed_date":"2015-06-05","scope":"insider","n_lines":2},{"id":8750370,"accession":"0001209191-15-050701","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-050701","line_url":"/filing/0001209191-15-050701#line-1","is_derivative":false,"issuer_cik":"0001198321","issuer_name":"ZS Pharma, Inc.","issuer_ticker":"ZSPH","issuer_name_source":null,"issuer_url":"/issuer/0001198321","owner_cik":null,"owner_name":"JANNEY DANIEL; CHAMPSI FARAH; Alta Partners Management VIII, LLC; NOHRA GUY P; Alta Partners VIII, L.P.","owner_display_name":"JANNEY DANIEL","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23189.0,"shares_display":"23,189","price_per_share":56.6,"price_display":"56.60","price_state":"stated","total_value":1312497.4,"total_display":"1,312,497.40","total_whole":"1,312,497","shares_owned_after":2910478.0,"shares_owned_after_display":"2,910,478","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-03","filed_date":"2015-06-05","scope":"insider"},{"id":8866347,"accession":"0001209191-15-049205","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-15-049205","line_url":"/filing/0001209191-15-049205#line-4","is_derivative":false,"issuer_cik":"0001198321","issuer_name":"ZS Pharma, Inc.","issuer_ticker":"ZSPH","issuer_name_source":null,"issuer_url":"/issuer/0001198321","owner_cik":null,"owner_name":"Alta Partners VIII, L.P.; JANNEY DANIEL; Alta Partners Management VIII, LLC; NOHRA GUY P; CHAMPSI FARAH","owner_display_name":"Alta Partners VIII, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":84342.0,"shares_display":"84,342","price_per_share":56.77,"price_display":"56.77","price_state":"stated","total_value":4788095.34,"total_display":"4,788,095.34","total_whole":"4,788,095","shares_owned_after":2933667.0,"shares_owned_after_display":"2,933,667","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-02","filed_date":"2015-06-02","scope":"insider"},{"id":8866345,"accession":"0001209191-15-049205","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-049205","line_url":"/filing/0001209191-15-049205#line-3","is_derivative":false,"issuer_cik":"0001198321","issuer_name":"ZS Pharma, Inc.","issuer_ticker":"ZSPH","issuer_name_source":null,"issuer_url":"/issuer/0001198321","owner_cik":null,"owner_name":"Alta Partners VIII, L.P.; JANNEY DANIEL; Alta Partners Management VIII, LLC; NOHRA GUY P; CHAMPSI FARAH","owner_display_name":"Alta Partners VIII, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":72520.0,"shares_display":"72,520","price_per_share":58.0,"price_display":"58.00","price_state":"stated","total_value":4206160.0,"total_display":"4,206,160.00","total_whole":"4,206,160","shares_owned_after":3018009.0,"shares_owned_after_display":"3,018,009","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-01","filed_date":"2015-06-02","scope":"insider"},{"id":8866343,"accession":"0001209191-15-049205","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-049205","line_url":"/filing/0001209191-15-049205","is_derivative":false,"issuer_cik":"0001198321","issuer_name":"ZS Pharma, Inc.","issuer_ticker":"ZSPH","issuer_name_source":null,"issuer_url":"/issuer/0001198321","owner_cik":null,"owner_name":"Alta Partners VIII, L.P.; JANNEY DANIEL; Alta Partners Management VIII, LLC; NOHRA GUY P; CHAMPSI FARAH","owner_display_name":"Alta Partners VIII, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":139561.0,"shares_display":"139,561","price_per_share":58.74161972184206,"price_display":"58.74","price_state":"stated","total_value":8198039.19,"total_display":"8,198,039.19","total_whole":"8,198,039","shares_owned_after":3105225.0,"shares_owned_after_display":"3,105,225","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-29","filed_date":"2015-06-02","scope":"insider","n_lines":2},{"id":6709969,"accession":"0001209191-14-074256","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-074256","line_url":"/filing/0001209191-14-074256#line-1","is_derivative":false,"issuer_cik":"0001198321","issuer_name":"TREVENA INC","issuer_ticker":"TRVN","issuer_name_source":null,"issuer_url":"/issuer/0001198321","owner_cik":null,"owner_name":"CHAMPSI FARAH; Alta Partners VIII, L.P.; Alta Partners Management VIII, LLC; JANNEY DANIEL; NOHRA GUY P","owner_display_name":"CHAMPSI FARAH","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500000.0,"shares_display":"500,000","price_per_share":4.0,"price_display":"4.00","price_state":"stated","total_value":2000000.0,"total_display":"2,000,000.00","total_whole":"2,000,000","shares_owned_after":4390262.0,"shares_owned_after_display":"4,390,262","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-12-10","filed_date":"2014-12-10","scope":"insider"},{"id":7075891,"accession":"0001209191-14-071297","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-14-071297","line_url":"/filing/0001209191-14-071297","is_derivative":false,"issuer_cik":"0001198321","issuer_name":"Neothetics, Inc.","issuer_ticker":"NEOT","issuer_name_source":null,"issuer_url":"/issuer/0001198321","owner_cik":null,"owner_name":"Alta Partners VIII, L.P.; JANNEY DANIEL; Alta Partners Management VIII, LLC; NOHRA GUY P; CHAMPSI FARAH","owner_display_name":"Alta Partners VIII, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":149286.0,"shares_display":"149,286","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":2090004.0,"total_display":"2,090,004.00","total_whole":"2,090,004","shares_owned_after":2583325.0,"shares_owned_after_display":"2,583,325","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-11-25","filed_date":"2014-11-25","scope":"insider","n_lines":3},{"id":7075884,"accession":"0001209191-14-071297","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-14-071297","line_url":"/filing/0001209191-14-071297#line-5","is_derivative":false,"issuer_cik":"0001198321","issuer_name":"Neothetics, Inc.","issuer_ticker":"NEOT","issuer_name_source":null,"issuer_url":"/issuer/0001198321","owner_cik":null,"owner_name":"Alta Partners VIII, L.P.; JANNEY DANIEL; Alta Partners Management VIII, LLC; NOHRA GUY P; CHAMPSI FARAH","owner_display_name":"Alta Partners VIII, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":70000.0,"shares_display":"70,000","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":980000.0,"total_display":"980,000.00","total_whole":"980,000","shares_owned_after":2667024.0,"shares_owned_after_display":"2,667,024","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-11-25","filed_date":"2014-11-25","scope":"insider"},{"id":7055269,"accession":"0001209191-14-064204","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-064204","line_url":"/filing/0001209191-14-064204#line-1","is_derivative":false,"issuer_cik":"0001198321","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001198321","owner_cik":null,"owner_name":"CHAMPSI FARAH; NOHRA GUY P; Alta Partners VIII, L.P.; Alta Partners Management VIII, LLC","owner_display_name":"CHAMPSI FARAH","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500000.0,"shares_display":"500,000","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":10000000.0,"total_display":"10,000,000.00","total_whole":"10,000,000","shares_owned_after":2552189.0,"shares_owned_after_display":"2,552,189","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-10-21","filed_date":"2014-10-21","scope":"insider"},{"id":6250936,"accession":"0001123292-14-000778","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001123292-14-000778","line_url":"/filing/0001123292-14-000778#line-5","is_derivative":false,"issuer_cik":"0001198321","issuer_name":"Immune Design Corp.","issuer_ticker":"IMDZ","issuer_name_source":null,"issuer_url":"/issuer/0001198321","owner_cik":null,"owner_name":"CHAMPSI FARAH; NOHRA GUY P; JANNEY DANIEL; Alta Partners Management VIII, LLC; Alta Partners VIII, L.P.","owner_display_name":"CHAMPSI FARAH","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":299559.0,"shares_display":"299,559","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":3594708.0,"total_display":"3,594,708.00","total_whole":"3,594,708","shares_owned_after":2482775.0,"shares_owned_after_display":"2,482,775","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-07-29","filed_date":"2014-07-31","scope":"insider"},{"id":6295480,"accession":"0001209191-14-043445","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-043445","line_url":"/filing/0001209191-14-043445#line-2","is_derivative":false,"issuer_cik":"0001198321","issuer_name":"ZS Pharma, Inc.","issuer_ticker":"ZSPH","issuer_name_source":null,"issuer_url":"/issuer/0001198321","owner_cik":null,"owner_name":"Alta Partners VIII, L.P.; CHAMPSI FARAH; NOHRA GUY P; Alta Partners Management VIII, LLC; JANNEY DANIEL","owner_display_name":"Alta Partners VIII, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200000.0,"shares_display":"200,000","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":3600000.0,"total_display":"3,600,000.00","total_whole":"3,600,000","shares_owned_after":3230090.0,"shares_owned_after_display":"3,230,090","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-23","filed_date":"2014-06-25","scope":"insider"},{"id":6556084,"accession":"0001209191-14-024134","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-024134","line_url":"/filing/0001209191-14-024134#line-2","is_derivative":false,"issuer_cik":"0001198321","issuer_name":"APPLIED GENETIC TECHNOLOGIES CORP","issuer_ticker":"AGTC","issuer_name_source":null,"issuer_url":"/issuer/0001198321","owner_cik":null,"owner_name":"JANNEY DANIEL; Alta Partners Management VIII, LLC; NOHRA GUY P; CHAMPSI FARAH; Alta Partners VIII, L.P.","owner_display_name":"JANNEY DANIEL","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":155645.0,"shares_display":"155,645","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":1867740.0,"total_display":"1,867,740.00","total_whole":"1,867,740","shares_owned_after":2984400.0,"shares_owned_after_display":"2,984,400","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-04-01","filed_date":"2014-04-01","scope":"insider"},{"id":6699383,"accession":"0001209191-14-008251","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-14-008251","line_url":"/filing/0001209191-14-008251#line-5","is_derivative":false,"issuer_cik":"0001198321","issuer_name":"TREVENA INC","issuer_ticker":"TRVN","issuer_name_source":null,"issuer_url":"/issuer/0001198321","owner_cik":null,"owner_name":"JANNEY DANIEL; Alta Partners VIII, L.P.; NOHRA GUY P; CHAMPSI FARAH; Alta Partners Management VIII, LLC","owner_display_name":"JANNEY DANIEL","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":472410.0,"shares_display":"472,410","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":3306870.0,"total_display":"3,306,870.00","total_whole":"3,306,870","shares_owned_after":3890262.0,"shares_owned_after_display":"3,890,262","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-02-05","filed_date":"2014-02-07","scope":"insider"},{"id":5445138,"accession":"0001179110-13-011144","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-13-011144","line_url":"/filing/0001179110-13-011144#line-2","is_derivative":false,"issuer_cik":"0001198321","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001198321","owner_cik":null,"owner_name":"CHAMPSI FARAH; Alta Partners Management VIII, LLC; Alta Partners VIII, L.P.; NOHRA GUY P","owner_display_name":"CHAMPSI FARAH","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":235714.0,"shares_display":"235,714","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":3299996.0,"total_display":"3,299,996.00","total_whole":"3,299,996","shares_owned_after":2052189.0,"shares_owned_after_display":"2,052,189","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-07-01","filed_date":"2013-07-01","scope":"insider"},{"id":7627289,"accession":"0001209191-10-002502","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-10-002502","line_url":"/filing/0001209191-10-002502","is_derivative":false,"issuer_cik":"0001106287","issuer_name":"ANESIVA, INC.","issuer_ticker":"ANSV","issuer_name_source":null,"issuer_url":"/issuer/0001106287","owner_cik":null,"owner_name":"ALTA EMBARCADERO PARTNERS III LLC; Alta Partners Management VIII, LLC; ALTA CALIFORNIA PARTNERS III LP; CHAMPSI FARAH; GRUENER GARRETT; NOHRA GUY P; Alta Partners VIII, L.P.","owner_display_name":"ALTA EMBARCADERO PARTNERS III LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stocks","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":404650.0,"shares_display":"404,650","price_per_share":0.0918,"price_display":"0.09","price_state":"stated","total_value":37146.87,"total_display":"37,146.87","total_whole":"37,147","shares_owned_after":5799841.0,"shares_owned_after_display":"5,799,841","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-01-06","filed_date":"2010-01-08","scope":"insider","n_lines":3}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001564824","name":"Allakos Inc.","url":"/issuer/0001564824","role":"Ten percent owner","n_filings":1,"first_seen":"2018-07-23","last_seen":"2018-07-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001618835","name":"Neothetics, Inc.","url":"/issuer/0001618835","role":"Ten percent owner, Other","n_filings":3,"first_seen":"2014-11-25","last_seen":"2015-12-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001459266","name":"ZS Pharma, Inc.","url":"/issuer/0001459266","role":"Ten percent owner","n_filings":4,"first_seen":"2014-06-25","last_seen":"2015-06-09"},{"type":"issuer","type_label":"ISSUER","cik":"0001429560","name":"TREVENA INC","url":"/issuer/0001429560","role":"Ten percent owner","n_filings":2,"first_seen":"2014-02-07","last_seen":"2014-12-10"},{"type":"issuer","type_label":"ISSUER","cik":"0001434868","name":"Esperion Therapeutics, Inc.","url":"/issuer/0001434868","role":"Ten percent owner","n_filings":2,"first_seen":"2013-07-01","last_seen":"2014-10-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001437786","name":"Immune Design Corp.","url":"/issuer/0001437786","role":"Ten percent owner","n_filings":1,"first_seen":"2014-07-31","last_seen":"2014-07-31"},{"type":"issuer","type_label":"ISSUER","cik":"0001273636","name":"APPLIED GENETIC TECHNOLOGIES CORP","url":"/issuer/0001273636","role":"Ten percent owner","n_filings":1,"first_seen":"2014-04-01","last_seen":"2014-04-01"},{"type":"issuer","type_label":"ISSUER","cik":"0001131517","name":"ANESIVA, INC.","url":"/issuer/0001131517","role":"Ten percent owner","n_filings":1,"first_seen":"2010-01-08","last_seen":"2010-01-08"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001399894","retrieved_at":"2026-08-25T23:19:50+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}